SAP a new therapeutic target in Alzheimer’s disease
Research led by Professor Mark Pepys FRS has identified a protein known as serum amyloid P component (SAP) as a possible therapeutic target in Alzheimer?s disease. – New therapeutic approaches in Alzheimer’s disease are urgently needed. Work led by Professor Mark Pepys FRS over more than 20 years has identified a protein known as serum amyloid P component (SAP) as a possible therapeutic target in Alzheimer’s disease.